Nimbus Therapeutics Company

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Technology: Alternative Medicine, Biotechnology, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2009-01-01
Employees Number: 11-50
Investors Number: 15
Total Funding: 302000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-07-13
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership